CONSTANT LEVERAGE LONG - UCB Share Price

L5PFB

FRBNPP03GNB3

Market Closed - Euronext Paris 10:00:01 31/05/2024 pm IST
6.155 ^EUR	+6.21%

Current month	+8.72%
1 month	+8.72%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB : Acquisition of own shares	31/05	PU
UCB : Commitment to Innovation in Drug Development	29/05	PU
UCB : announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa	23/05	PU
UCB - Acquisition of own shares	20/05	AQ

More news

Quotes 5-day view

Date	Price	Change
31/24/31	6.235	+7.59%
30/24/30	5.795	-3.26%
29/24/29	5.99	+0.17%
28/24/28	5.98	-3.63%
27/24/27	6.205	-2.13%

Real-time Euronext Paris

Last update May 31, 2024 at 10:00 pm IST

More quotes

Static data

Product type	Produits Exotiques
Buy / Sell	CALL
Underlying	UCB
Issuer	BNP Paribas
	L5PFB
ISIN	FRBNPP03GNB3
Date issued	21/01/2022
Maturity	Unlimited
Parity	1 : 1
Emission price	10 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	27.08 €
Lowest since issue	0.333 €
Spread	0.29 €
Spread %	4.59%

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

128.6 EUR

Average target price

126.4 EUR

Spread / Average Target

-1.76%

Consensus